Skip to content

Paul V Maier, Director at Eton Pharmaceuticals, sold ETON on Aug 28, 2026

Data as of Oct 16

▼ SELL$7.9K128 shares at $61.77Paul V Maier DirectorETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Aug 28, 2026
Disclosed
Aug 28, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Paul V Maier, Director at Eton Pharmaceuticals, sold ETON on Aug 28, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
−15.8%
after the sale
Similar stocks (XLV) since disclosure
+3.2%
XLV — its sector index fund

Change in closing price from Aug 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLPaul V Maier DirectorETON Eton Pharmaceuticals, Inc.$812Kdisclosed Aug 28 · filed the same day
  2. ▼ SELLPaul V Maier DirectorETON Eton Pharmaceuticals, Inc.$2.1Mdisclosed Aug 28 · filed the same day

See every trade on ETON →